Annual Retained Earnings
-$1.62 B
-$135.12 M-9.08%
31 December 2023
Summary:
Inovio Pharmaceuticals annual retained earnings is currently -$1.62 billion, with the most recent change of -$135.12 million (-9.08%) on 31 December 2023. During the last 3 years, it has fallen by -$716.77 million (-79.10%). INO annual retained earnings is now -8014.83% below its all-time high of -$20.00 million, reached on 31 March 1999.INO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.71 B
-$25.17 M-1.49%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly retained earnings is currently -$1.71 billion, with the most recent change of -$25.17 million (-1.49%) on 30 September 2024. Over the past year, it has dropped by -$112.88 million (-7.06%). INO quarterly retained earnings is now -9732.40% below its all-time high of -$17.40 million, reached on 31 December 1998.INO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.1% | -7.1% |
| 3 y3 years | -79.1% | -55.1% |
| 5 y5 years | -161.6% | -143.7% |
INO Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -79.1% | at low | -55.1% | at low |
| 5 y | 5 years | -161.6% | at low | -143.7% | at low |
| alltime | all time | -8014.8% | at low | -9732.4% | at low |
Inovio Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.71 B(+1.5%) |
| June 2024 | - | -$1.69 B(+1.9%) |
| Mar 2024 | - | -$1.65 B(+1.9%) |
| Dec 2023 | -$1.62 B(+9.1%) | -$1.62 B(+1.6%) |
| Sept 2023 | - | -$1.60 B(+2.2%) |
| June 2023 | - | -$1.56 B(+2.3%) |
| Mar 2023 | - | -$1.53 B(+2.7%) |
| Dec 2022 | -$1.49 B(+23.0%) | -$1.49 B(+3.8%) |
| Sept 2022 | - | -$1.43 B(+2.7%) |
| June 2022 | - | -$1.40 B(+8.4%) |
| Mar 2022 | - | -$1.29 B(+6.4%) |
| Dec 2021 | -$1.21 B(+33.5%) | -$1.21 B(+9.7%) |
| Sept 2021 | - | -$1.10 B(+5.8%) |
| June 2021 | - | -$1.04 B(+8.6%) |
| Mar 2021 | - | -$960.60 M(+6.0%) |
| Dec 2020 | -$906.20 M(+22.5%) | -$906.20 M(+2.8%) |
| Sept 2020 | - | -$881.86 M(-2.1%) |
| June 2020 | - | -$901.03 M(+16.7%) |
| Mar 2020 | - | -$772.33 M(+4.4%) |
| Dec 2019 | -$739.79 M(+19.2%) | -$739.79 M(+5.4%) |
| Sept 2019 | - | -$702.12 M(+3.4%) |
| June 2019 | - | -$679.03 M(+4.5%) |
| Mar 2019 | - | -$649.65 M(+4.7%) |
| Dec 2018 | -$620.43 M(+18.5%) | -$620.43 M(+5.7%) |
| Sept 2018 | - | -$587.13 M(+4.5%) |
| June 2018 | - | -$562.11 M(+1.2%) |
| Mar 2018 | - | -$555.48 M(+6.1%) |
| Dec 2017 | -$523.36 M(+20.4%) | -$523.36 M(+4.3%) |
| Sept 2017 | - | -$501.85 M(+7.3%) |
| June 2017 | - | -$467.72 M(+2.1%) |
| Mar 2017 | - | -$458.24 M(+5.4%) |
| Dec 2016 | -$434.84 M(+20.4%) | -$434.84 M(+6.4%) |
| Sept 2016 | - | -$408.60 M(+5.4%) |
| June 2016 | - | -$387.85 M(+5.1%) |
| Mar 2016 | - | -$369.14 M(+2.2%) |
| Dec 2015 | -$361.10 M(+8.8%) | -$361.10 M(+5.2%) |
| Sept 2015 | - | -$343.15 M(-1.6%) |
| June 2015 | - | -$348.74 M(+1.8%) |
| Mar 2015 | - | -$342.49 M(+3.2%) |
| Dec 2014 | -$331.91 M(+12.2%) | -$331.91 M(+2.3%) |
| Sept 2014 | - | -$324.50 M(+2.3%) |
| June 2014 | - | -$317.32 M(+3.5%) |
| Mar 2014 | - | -$306.61 M(+3.7%) |
| Dec 2013 | -$295.79 M(+28.7%) | -$295.79 M(+5.5%) |
| Sept 2013 | - | -$280.33 M(+12.4%) |
| June 2013 | - | -$249.46 M(+4.5%) |
| Mar 2013 | - | -$238.60 M(+3.8%) |
| Dec 2012 | -$229.76 M(+9.4%) | -$229.76 M(+0.3%) |
| Sept 2012 | - | -$229.10 M(+3.0%) |
| June 2012 | - | -$222.48 M(+1.9%) |
| Mar 2012 | - | -$218.35 M(+3.9%) |
| Dec 2011 | -$210.09 M | -$210.09 M(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | -$204.61 M(+2.3%) |
| June 2011 | - | -$200.07 M(+1.4%) |
| Mar 2011 | - | -$197.25 M(+1.2%) |
| Dec 2010 | -$194.84 M(+9.9%) | -$194.84 M(+3.3%) |
| Sept 2010 | - | -$188.54 M(+0.8%) |
| June 2010 | - | -$187.13 M(+4.2%) |
| Mar 2010 | - | -$179.52 M(+1.3%) |
| Dec 2009 | -$177.22 M(+16.0%) | -$177.22 M(+4.3%) |
| Sept 2009 | - | -$169.88 M(+1.8%) |
| June 2009 | - | -$166.93 M(+6.8%) |
| Mar 2009 | - | -$156.28 M(+2.3%) |
| Dec 2008 | -$152.81 M(+9.3%) | -$152.81 M(+2.4%) |
| Sept 2008 | - | -$149.24 M(+1.6%) |
| June 2008 | - | -$146.89 M(+2.8%) |
| Mar 2008 | - | -$142.87 M(+2.2%) |
| Dec 2007 | -$139.85 M(+8.7%) | -$139.85 M(-1.5%) |
| Sept 2007 | - | -$141.94 M(+3.4%) |
| June 2007 | - | -$137.32 M(+3.4%) |
| Mar 2007 | - | -$132.84 M(+3.3%) |
| Dec 2006 | -$128.62 M(+12.6%) | -$128.62 M(+4.1%) |
| Sept 2006 | - | -$123.50 M(+2.9%) |
| June 2006 | - | -$120.06 M(+2.6%) |
| Mar 2006 | - | -$116.98 M(+2.4%) |
| Dec 2005 | -$114.27 M(+30.0%) | -$114.27 M(+11.3%) |
| Sept 2005 | - | -$102.71 M(+3.2%) |
| June 2005 | - | -$99.52 M(+2.4%) |
| Mar 2005 | - | -$97.19 M(+10.6%) |
| Dec 2004 | -$87.91 M(+15.4%) | -$87.91 M(+4.8%) |
| Sept 2004 | - | -$83.89 M(+4.6%) |
| June 2004 | - | -$80.22 M(+3.0%) |
| Mar 2004 | - | -$77.88 M(+2.2%) |
| Dec 2003 | -$76.20 M(+42.9%) | -$76.20 M(+22.0%) |
| Sept 2003 | - | -$62.47 M(+14.5%) |
| June 2003 | - | -$54.55 M(+2.6%) |
| Mar 2003 | - | -$53.15 M(-0.3%) |
| Dec 2002 | -$53.33 M(+12.6%) | -$53.33 M(+3.0%) |
| Sept 2002 | - | -$51.75 M(+2.8%) |
| June 2002 | - | -$50.36 M(+3.1%) |
| Mar 2002 | - | -$48.82 M(+7.5%) |
| Dec 2001 | -$47.36 M(+15.5%) | - |
| Sept 2001 | - | -$45.40 M(+3.9%) |
| June 2001 | - | -$43.68 M(+6.5%) |
| Mar 2001 | - | -$41.00 M(+15.3%) |
| Mar 2001 | -$41.00 M(+38.5%) | - |
| Dec 2000 | - | -$35.57 M(+6.5%) |
| Sept 2000 | - | -$33.41 M(+6.0%) |
| June 2000 | - | -$31.51 M(+6.4%) |
| Mar 2000 | -$29.60 M(+48.0%) | -$29.60 M(+8.8%) |
| Dec 1999 | - | -$27.20 M(+7.9%) |
| Sept 1999 | - | -$25.20 M(+10.0%) |
| June 1999 | - | -$22.90 M(+14.5%) |
| Mar 1999 | -$20.00 M | -$20.00 M(+14.9%) |
| Dec 1998 | - | -$17.40 M |
FAQ
- What is Inovio Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual retained earnings year-on-year change?
- What is Inovio Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly retained earnings year-on-year change?
What is Inovio Pharmaceuticals annual retained earnings?
The current annual retained earnings of INO is -$1.62 B
What is the all time high annual retained earnings for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual retained earnings is -$20.00 M
What is Inovio Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, INO annual retained earnings has changed by -$135.12 M (-9.08%)
What is Inovio Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of INO is -$1.71 B
What is the all time high quarterly retained earnings for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly retained earnings is -$17.40 M
What is Inovio Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, INO quarterly retained earnings has changed by -$112.88 M (-7.06%)